Global X Japan Co. Ltd. Has $549,000 Stake in Cardinal Health, Inc. (NYSE:CAH)

Global X Japan Co. Ltd. boosted its stake in Cardinal Health, Inc. (NYSE:CAH) by 6.3% during the 4th quarter, HoldingsChannel reports. The fund owned 4,638 shares of the company’s stock after acquiring an additional 276 shares during the quarter. Global X Japan Co. Ltd.’s holdings in Cardinal Health were worth $549,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the company. Czech National Bank raised its position in Cardinal Health by 7.0% in the 3rd quarter. Czech National Bank now owns 49,673 shares of the company’s stock valued at $5,490,000 after buying an additional 3,259 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Cardinal Health by 34.0% during the 3rd quarter. GAMMA Investing LLC now owns 3,557 shares of the company’s stock worth $393,000 after purchasing an additional 902 shares in the last quarter. Future Financial Wealth Managment LLC acquired a new stake in Cardinal Health in the third quarter valued at $55,000. Pensionfund Sabic bought a new stake in shares of Cardinal Health in the 3rd quarter valued at about $1,105,000. Finally, Perpetual Ltd acquired a new stake in Cardinal Health in the 3rd quarter valued at about $208,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.3 %

Shares of CAH stock opened at $127.07 on Friday. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $132.84. The firm has a market capitalization of $30.70 billion, a price-to-earnings ratio of 23.71, a PEG ratio of 1.46 and a beta of 0.63. The business’s 50-day moving average price is $122.35 and its 200-day moving average price is $114.92.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.92 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. Cardinal Health’s payout ratio is currently 37.69%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on CAH. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. JPMorgan Chase & Co. lifted their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a report on Tuesday. Mizuho started coverage on shares of Cardinal Health in a report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price target on the stock. UBS Group upped their price objective on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a report on Monday, November 4th. Finally, Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price target for the company from $132.00 to $145.00 in a research report on Monday, January 6th. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $136.87.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.